Conventional Cartilaginous Tumors: Evaluation and Treatment. Issue 5 (May 2021)

• Record Type: Journal Article
• Authors: Wells, Matthew E.; Eckhoff, Michael D.; Kafchinski, Lisa A.; Polfer, Elizabeth M.; Potter, Benjamin K.
• Is Part Of: JBJS reviews. Volume 9:Issue 5(2021)
• Publication Date: 2021-05
• Subjects: Bones -- Surgery -- Periodicals; Joints -- Surgery -- Periodicals; Orthopedics -- Periodicals; Orthopedics; General Surgery; Bone Diseases; Joint Diseases; Bones -- Surgery; Joints -- Surgery; Orthopedics; Periodicals; Electronic journals; Periodicals; 617.47
• DOI: 10.2106/JBJS.RVW.20.00159
• Languages: English
• ISSNs: 2329-9185

Abstract

Abstract : Enchondromas are benign cartilaginous lesions that rarely require surgical intervention. Atypical cartilaginous tumors (ACTs), also referred to as grade-1 chondrosarcomas, may be managed without any intervention or with extended intralesional curettage and bone-void filling. High-grade chondrosarcomas, or grade-2 and 3 chondrosarcomas, should be managed aggressively with wide resection. Chemotherapy and radiation do not currently play a role in the treatment of chondrosarcomas. Differentiating an enchondroma from an ACT and an ACT from a high-grade chondrosarcoma can be difficult and requires clinical experience, radiographic and advanced imaging, and possibly a biopsy. Ultimately, a multidisciplinary team that includes a musculoskeletal oncologist, a radiologist, and a pathologist is needed to make the most appropriate diagnosis and treatment plan for each patient.